Skip to main content
Oxford Biomedica PLC logo

Oxford Biomedica PLC - Investor Relations & Filings

Listed IPO Apr 2001
Ticker · OXB ISIN · GB00BDFBVT43 LEI · 213800S1GVQNXQ15K851 IL Manufacturing
Open in API
Filings indexed 926 across all filing types
Latest filing 2026-07-08 Major Shareholding Noti…
Country GB United Kingdom
Listing IL OXB · 7 venues

About Oxford Biomedica PLC

https://www.oxb.com/

Oxford Biomedica (OXB) is a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. A pioneer in the field, the company has extensive experience in viral vectors, the enabling technology for many advanced therapies. OXB provides end-to-end services to pharmaceutical and biotechnology partners, supporting programs from preclinical development through to commercial launch. Its core expertise includes the development and GMP manufacturing of various vector types, including lentivirus, adeno-associated virus (AAV), and adenovirus. The company offers proprietary technologies like its LentiVector™ platform, the first commercially approved lentiviral system, and its inAAVate™ platform for AAV, in addition to tech-transfer capabilities.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed with the London Stock Exchange. It details the acquisition of voting rights by M&G Plc in Oxford Biomedica PLC, crossing the 5% threshold. This is a standard regulatory disclosure for major shareholding notifications, which corresponds to the 'Major Shareholding Notification' (MRQ) category.
2026-07-08 English
Total Voting Rights
Regulatory Filings Classification · 100% confidence The document is a standard 'Total Voting Rights' announcement issued in accordance with the FCA's Disclosure Guidance and Transparency Rules. It provides the total number of voting rights and issued share capital to assist shareholders with regulatory notification requirements. This type of filing is a routine regulatory disclosure and does not represent a change in share capital (SHA), a transaction in own shares (POS), or a major shareholding notification (MRQ). Therefore, it falls under the RNS (Regulatory Filings) category.
2026-07-01 English
Admission to Trading
Share Issue/Capital Change Classification · 100% confidence The document is an official notification from Oxford Biomedica PLC regarding the admission of new shares to trading on the London Stock Exchange following the exercise of employee share schemes (LTIP, DBP, SAYE, ESOS). This falls under the category of share issuance and capital changes, specifically matching the definition for 'Share Issue/Capital Change' (SHA).
2026-06-22 English
Admission to trading application
Share Issue/Capital Change Classification · 100% confidence The document is an announcement regarding an application for the admission to trading of new ordinary shares issued under various employee share schemes (LTIP, DBP, SAYE, ESOS). This constitutes a change in the company's capital structure through the issuance of new shares. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2026-06-17 English
OXB Capital Markets Event
Report Publication Announcement Classification · 95% confidence The document is an announcement regarding an upcoming 'Capital Markets Event' hosted by Oxford Biomedica PLC. It provides details about the event's purpose, speakers, and how to register for the webcast. It explicitly states that 'No new information on current trading will be shared at the event.' According to the 'Menu vs Meal' rule, this is an announcement of an event/presentation rather than the presentation materials themselves, and it fits the definition of a Report Publication Announcement (RPA) as it invites stakeholders to an upcoming presentation/webcast.
2026-06-02 English
Total Voting Rights
Regulatory Filings Classification · 100% confidence The document is a standard 'Total Voting Rights' announcement issued in accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R. This type of filing is a regulatory requirement to inform shareholders of the total number of voting rights for transparency purposes. While it relates to share capital, it is not a transaction in own shares (POS) or a major shareholding notification (MRQ) by an investor; it is a routine regulatory disclosure of the denominator for transparency rules. Therefore, it falls under the 'Regulatory Filings' (RNS) category.
2026-06-01 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.